200 related articles for article (PubMed ID: 12877935)
61. Effects of a metabotropic, mglu5, glutamate receptor antagonist on ethanol consumption by genetic drinking rats.
McMillen BA; Crawford MS; Kulers CM; Williams HL
Alcohol Alcohol; 2005; 40(6):494-7. PubMed ID: 16186143
[TBL] [Abstract][Full Text] [Related]
62. The selective mGlu5 receptor antagonist MTEP, similar to NMDA receptor antagonists, induces social isolation in rats.
Koros E; Rosenbrock H; Birk G; Weiss C; Sams-Dodd F
Neuropsychopharmacology; 2007 Mar; 32(3):562-76. PubMed ID: 16794564
[TBL] [Abstract][Full Text] [Related]
63. 2-Methyl-6-(phenylethynyl)pyridine Hydrochloride Modulates Metabotropic Glutamate 5 Receptors Endogenously Expressed in Zebrafish Brain.
Albasanz JL; Santana S; Guzman-Sanchez F; León D; Burgos JS; Martín M
ACS Chem Neurosci; 2016 Dec; 7(12):1690-1697. PubMed ID: 27635438
[TBL] [Abstract][Full Text] [Related]
64. Brain concentrations of mGluR5 negative allosteric modulator MTEP in relation to receptor occupancy--Comparison to MPEP.
Nagel J; Greco S; Parsons CG; Flik G; Tober C; Klein KU; Danysz W
Pharmacol Rep; 2015 Jun; 67(3):624-30. PubMed ID: 25933979
[TBL] [Abstract][Full Text] [Related]
65. Neuroprotective effect caused by MPEP, an antagonist of metabotropic glutamate receptor mGluR5, on seizures induced by pilocarpine in 21-day-old rats.
Jesse CR; Savegnago L; Rocha JB; Nogueira CW
Brain Res; 2008 Mar; 1198():197-203. PubMed ID: 18242586
[TBL] [Abstract][Full Text] [Related]
66. In vitro binding of a radio-labeled positive allosteric modulator for metabotropic glutamate receptor subtype 5.
Zysk JR; Spear N; Fieles W; Stein MM; Sygowski LS; King MM; Hoesch V; Hastings R; Brockel B; Do M; Ström P; Gadient R; Chhajlani V; Elmore CS; Maier DL
Synapse; 2013 Mar; 67(3):135-44. PubMed ID: 23150216
[TBL] [Abstract][Full Text] [Related]
67. Relationship between in vivo receptor occupancy and efficacy of metabotropic glutamate receptor subtype 5 allosteric modulators with different in vitro binding profiles.
Rook JM; Tantawy MN; Ansari MS; Felts AS; Stauffer SR; Emmitte KA; Kessler RM; Niswender CM; Daniels JS; Jones CK; Lindsley CW; Conn PJ
Neuropsychopharmacology; 2015 Feb; 40(3):755-65. PubMed ID: 25241804
[TBL] [Abstract][Full Text] [Related]
68. Analgesic effects of mGlu1 and mGlu5 receptor antagonists in the rat formalin test.
Sevostianova N; Danysz W
Neuropharmacology; 2006 Sep; 51(3):623-30. PubMed ID: 16793067
[TBL] [Abstract][Full Text] [Related]
69. Anxiolytic-like effects of group I metabotropic glutamate antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) in rats.
Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E; Pilc A
Pol J Pharmacol; 2000; 52(6):463-6. PubMed ID: 11334240
[TBL] [Abstract][Full Text] [Related]
70. The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison.
Ballard TM; Woolley ML; Prinssen E; Huwyler J; Porter R; Spooren W
Psychopharmacology (Berl); 2005 Apr; 179(1):218-29. PubMed ID: 15739074
[TBL] [Abstract][Full Text] [Related]
71. Activation of lateral hypothalamic mGlu1 and mGlu5 receptors elicits feeding in rats.
Charles JR; Duva MA; Ramirez GJ; Lara RL; Yang CR; Stanley BG
Neuropharmacology; 2014 Apr; 79():59-65. PubMed ID: 24219858
[TBL] [Abstract][Full Text] [Related]
72. Combined antagonism of glutamate mGlu5 and adenosine A2A receptors interact to regulate alcohol-seeking in rats.
Adams CL; Cowen MS; Short JL; Lawrence AJ
Int J Neuropsychopharmacol; 2008 Mar; 11(2):229-41. PubMed ID: 17517168
[TBL] [Abstract][Full Text] [Related]
73. Quantitative analysis reveals multiple mechanisms of allosteric modulation of the mGlu5 receptor in rat astroglia.
Bradley SJ; Langmead CJ; Watson JM; Challiss RA
Mol Pharmacol; 2011 May; 79(5):874-85. PubMed ID: 21321061
[TBL] [Abstract][Full Text] [Related]
74. Antidepressant-like effect of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist in the olfactory bulbectomized rats.
Wieronska JM; Szewczyk B; Branski P; Palucha A; Pilc A
Amino Acids; 2002; 23(1-3):213-6. PubMed ID: 12373540
[TBL] [Abstract][Full Text] [Related]
75. Kinetic and system bias as drivers of metabotropic glutamate receptor 5 allosteric modulator pharmacology.
Sengmany K; Hellyer SD; Albold S; Wang T; Conn PJ; May LT; Christopoulos A; Leach K; Gregory KJ
Neuropharmacology; 2019 May; 149():83-96. PubMed ID: 30763654
[TBL] [Abstract][Full Text] [Related]
76. The effect of the mGlu5 negative allosteric modulator MTEP and NMDA receptor partial agonist D-cycloserine on Pavlovian conditioned fear.
Handford CE; Tan S; Lawrence AJ; Kim JH
Int J Neuropsychopharmacol; 2014 Sep; 17(9):1521-32. PubMed ID: 24674862
[TBL] [Abstract][Full Text] [Related]
77. Inhibition of human hepatic CYP isoforms by mGluR5 antagonists.
Green MD; Jiang X; King CD
Life Sci; 2004 Jul; 75(8):947-53. PubMed ID: 15193955
[TBL] [Abstract][Full Text] [Related]
78. Anxiolytic-like action of MTEP expressed in the conflict drinking Vogel test in rats is serotonin dependent.
Stachowicz K; Gołembiowska K; Sowa M; Nowak G; Chojnacka-Wójcik E; Pilc A
Neuropharmacology; 2007 Nov; 53(6):741-8. PubMed ID: 17870136
[TBL] [Abstract][Full Text] [Related]
79. Antiaggressive effects of MPEP, a selective antagonist of mGlu5 receptors, in agonistic interactions between male mice.
Navarro JF; Postigo D; Martín M; Burón E
Eur J Pharmacol; 2006 Dec; 551(1-3):67-70. PubMed ID: 17026995
[TBL] [Abstract][Full Text] [Related]
80. mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors.
Movsesyan VA; O'Leary DM; Fan L; Bao W; Mullins PG; Knoblach SM; Faden AI
J Pharmacol Exp Ther; 2001 Jan; 296(1):41-7. PubMed ID: 11123360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
